| Diabetes in sub-Saharan Africa: from clinical care to health policy The Lancet Diabetes and Endocrinology 5 (8), 622-667, 2017 | 461 | 2017 |
| How organizational structures in science shape spin-off firms: the biochemistry departments of Berkeley, Stanford, and UCSF and the birth of the biotech industry S Jong Industrial and Corporate Change 15 (2), 251-283, 2006 | 155 | 2006 |
| When publications lead to products: The open science conundrum in new product development S Jong, K Slavova Research Policy 43 (4), 645-654, 2014 | 111 | 2014 |
| Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease A Srivastava, S Jong, A Gola, R Gailer, S Morgan, K Sennett, S Tanwar, ... BMC gastroenterology 19, 1-15, 2019 | 99 | 2019 |
| Academic organizations and new industrial fields: Berkeley and Stanford after the rise of biotechnology S Jong Research Policy 37 (8), 1267-1282, 2008 | 90 | 2008 |
| Innovation in local economies: Germany in comparative context C Crouch, H Voelzkow OUP Oxford, 2009 | 66 | 2009 |
| University alliances and firm exploratory innovation: Evidence from therapeutic product development K Slavova, S Jong Technovation 107, 102310, 2021 | 31 | 2021 |
| Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercialization S Hassan, H Huang, K Warren, B Mahdavi, D Smith, S Jong, SS Farid Regenerative medicine 11 (3), 287-305, 2016 | 28 | 2016 |
| The development of Munich and Cambridge therapeutic biotech firms: A case study of institutional adaptation S Jong Innovation in Local Economies. Germany in Comparative Context, 121-138, 2009 | 22 | 2009 |
| Public funding for science and the value of corporate R&D projects; evidence from project initiation and termination decisions in cell therapy H Huang, S Jong Journal of management studies 56 (5), 1000-1039, 2019 | 15 | 2019 |
| Commercializing a disruptive technology S Jong Bioentrepreneur, 1-4, 2011 | 10 | 2011 |
| Entrepreneurship and marketplace formation in German biotechnology S Casper, SJK Chin, F Murray paper presented on annual retreat of Society for Comparative Research in San …, 2004 | 5 | 2004 |
| Keys to the kingdom SCK Wong, LS Sasportas, K Richardson, BR Gordon, MKP Jayatunga, ... Nature Biotechnology 33 (3), 232-236, 2015 | 4 | 2015 |
| How Industry Ties Shape the Organization of Science: Reorganizations at Berkeley and Stanford after the Birth of the Biotech Industry S Jong European Forum on the Role of Universities in Innovation Systems, European …, 2005 | 4 | 2005 |
| Tapping into Science; university collaborations, technological breadth, and new product development K Slavova, S Jong Academy of Management Proceedings 2019 (1), 16981, 2019 | 1 | 2019 |
| A probabilistic decision model using non-invasive fibrosis markers in Primary Care NAFLD pathways predicts increased cirrhosis detection rates and reduced overall healthcare … A Srivastava, S Jong, A Gola, L Fenlon, P Scantlebury, S Tanwar, H Liu, ... Hepatology 62, 920A-920A, 2015 | 1 | 2015 |
| When ambidexterity backfires: Strategic discipline in new technology ventures E Forti, S Jong Academy of Management Proceedings 2014 (1), 11111, 2014 | 1 | 2014 |
| When ambidexterity backfires: Strategic discipline in new technology ventures E Forti, S Jong Academy of Management Proceedings 2014 (1), 11111, 2014 | 1 | 2014 |
| When times get tough S Jong Bioentrepreneur, 1-3, 2009 | 1 | 2009 |
| The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparison SJ Ro-Ting Lin, Cheng-Kuan Lin, David C. Christiani, Ichiro Kawachi, Yawen ... Nature Scientific Reports 7, 2017 | | 2017 |
Emmanuel TsochatzisSheila Sherlock Liver Unit and UCL Institute of Liver and Digestive HealthVerified email at ucl.ac.uk
